SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000059478-21-000004
Filing Date
2021-01-14
Accepted
2021-01-14 07:30:31
Documents
16
Period of Report
2021-01-13
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lly-20210113.htm   iXBRL 8-K 67432
2 EX-99.1 sulzbergerbodpressrelease-.htm EX-99.1 8683
8 image_01a.jpg GRAPHIC 4741
  Complete submission text file 0000059478-21-000004.txt   317922

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lly-20210113.xsd EX-101.SCH 4267
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lly-20210113_cal.xml EX-101.CAL 715
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lly-20210113_def.xml EX-101.DEF 18480
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lly-20210113_lab.xml EX-101.LAB 38670
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lly-20210113_pre.xml EX-101.PRE 19470
9 EXTRACTED XBRL INSTANCE DOCUMENT lly-20210113_htm.xml XML 25265
Mailing Address LILLY CORPORATE CENTER DROP CODE 1094 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1094 INDIANAPOLIS IN 46285 3172762000
ELI LILLY & Co (Filer) CIK: 0000059478 (see all company filings)

IRS No.: 350470950 | State of Incorp.: IN | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-06351 | Film No.: 21527496
SIC: 2834 Pharmaceutical Preparations